Company Overview of Aura Biosciences, Inc.
Aura Biosciences, Inc. develops therapies that target and destroy cancer cells. It focuses on developing therapies that pinpoint solid tumors and metastases without harming surrounding tissue, enabling targeted treatment across a range of cancers. The company’s portfolio includes AU-011, a product that comprises a viral-like particle (VLP) that binds selectively to cancer cells in the eye, and upon activation with an ophthalmic laser the small molecule selectively destroys the membrane of cancer cells, killing them without damaging the overlaying retina. The company was founded in 2007 and is based in Cambridge, Massachusetts.
85 Bolton Street
Cambridge, MA 02140
Founded in 2007
Key Executives for Aura Biosciences, Inc.
Aura Biosciences, Inc. Key Developments
Similar Private Companies By Industry
|Dartmouth-Hitchcock Clinic||United States|
|GlaxoSmithKline Consumer Healthcare, L.P.||United States|
|Celeres Pharmaceuticals, Inc.||United States|
|ImmusanT, Inc.||United States|
|Nascime Limited||United States|
Recent Private Companies Transactions
February 24, 2015
To contact Aura Biosciences, Inc., please visit www.aurabiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.